Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 1995Arteriosclerosis Thrombosis and Vascular Biology

Plasminogen Activator Expression in Human Atherosclerotic Lesions

View Full Paper
Ask AI
Bookmark
Share

Authors

FLFlorea LupuVA Palo Alto Health Care SystemDHDominik HeimUniversity Hospital of BaselFBF BachmannCross-Cutting Cardiology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lupu et al. (1995) studied this question.

synapsesocial.com/papers/6a76c33cf6749a0058ec31c7https://doi.org/10.1161/01.atv.15.9.1444
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture.1989 · 908 citations
  2. 2Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity.1990 · 545 citations
  3. 3Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin.1990 · 745 citations
  4. 4Preoperative Identification of Patients at High Risk of Deep Venous Thrombosis Despite Prophylaxis in Total Hip Replacement1988 · 47 citations
  5. 5Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.1992 · 548 citations